Regulation of antioxidants in cancer

Mol Cell. 2024 Jan 4;84(1):23-33. doi: 10.1016/j.molcel.2023.11.001. Epub 2023 Nov 28.

Abstract

Scientists in this field often joke, "If you don't have a mechanism, say it's ROS." Seemingly connected to every biological process ever described, reactive oxygen species (ROS) have numerous pleiotropic roles in physiology and disease. In some contexts, ROS act as secondary messengers, controlling a variety of signaling cascades. In other scenarios, they initiate damage to macromolecules. Finally, in their worst form, ROS are deadly to cells and surrounding tissues. A set of molecules with detoxifying abilities, termed antioxidants, is the direct counterpart to ROS. Notably, antioxidants exist in the public domain, touted as a "cure-all" for diseases. Research has disproved many of these claims and, in some cases, shown the opposite. Of all the diseases, cancer stands out in its paradoxical relationship with antioxidants. Although the field has made numerous strides in understanding the roles of antioxidants in cancer, many questions remain.

Keywords: NRF2; ROS; antioxidants; cancer; glutathione; oxidative stress.

Publication types

  • Review

MeSH terms

  • Antioxidants*
  • Humans
  • Neoplasms* / genetics
  • Oxidative Stress
  • Reactive Oxygen Species
  • Signal Transduction

Substances

  • Antioxidants
  • Reactive Oxygen Species